Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: Nuclear HO-1 promotes vascular endothelial growth factor secretion

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 1919-1928

  Birrane, Gabriel ^a   Li, Huchun ^a   Yang, Suping ^a   Tachado, Souvenir D ^a   Seng, Seyha ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cigarette smoke; Nuclear heme oxygenase 1; Prostate cancer; Vascular endothelial growth factor

Indexed keywords

CIGARETTE SMOKE; HEME OXYGENASE 1; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN SECRETION; TRANSACTIVATION; UPREGULATION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL NUCLEUS; HEK293 CELLS; HEME OXYGENASE-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; SMOKING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876588731     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1910     Document Type: Article

References (44)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ and Ezzati M: The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med 6: e1000058, 2009.
3. Pryor WA and Stone K: Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686: 12-27, 1993.
4. Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210, 1999. (Pubitemid 29357186)
5. Portal-Nuñez S, Shankavaram UT, Rao M, Datrice N, Atay S, Aparicio M, Camphausen KA, Fernández-Salguero PM, Chang H, Lin P, Schrump DS, Garantziotis S, Cuttitta F and Zudaire E: Aryl hydrocarbon receptor-induced adrenomedullin mediates cigarette smoke carcinogenicity in humans and mice. Cancer Res 72: 5790-5800, 2012.
6. Zu K and Giovannucci E: Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 20: 1799-1810, 2009.
7. Tenhunen R, Marver HS and Schmid R: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 61: 748-755, 1968.
8. Kikuchi G, Yoshida T and Noguchi M: Heme oxygenase and heme degradation. Biochem Biophys Res Commun 338: 558-567, 2005. (Pubitemid 41540603)
9. Prawan A, Kundu JK and Surh YJ: Molecular basis of heme oxygenase-1 induction: implications for chemoprevention and chemoprotection. Antioxid Redox Signal 7: 1688-1703, 2005. (Pubitemid 41768002)
10. Maines MD and Abrahamsson PA: Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology 47: 727-733, 1996. (Pubitemid 26172743)
11. Maines MD and Gibbs PE: 30 some years of heme oxygenase: from a 'molecular wrecking ball' to a 'mesmerizing' trigger of cellular events. Biochem Biophys Res Commun 338: 568-577, 2005. (Pubitemid 41540604)
12. Jozkowicz A, Was H and Dulak J: Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9: 2099-2117, 2007. (Pubitemid 350059009)
13. Cherrington JM, Strawn LM and Shawver LK: New paradigms for the treatment of cancer: the role of anti-angiogenesis agents. Adv Cancer Res 79: 1-38, 2000.
14. Busserolles J, Megias J, Terencio MC and Alcaraz MJ: Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway. Int J Biochem Cell Biol 38: 1510-1517, 2006. (Pubitemid 43729295)
15. Chen X, Ding YW, Yang G, Bondoc F, Lee MJ, Yang CS: Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 21: 257-263, 2000. (Pubitemid 30098711)
16. Liu ZM, Chen GG, Ng EK, Leung WK, Sung JJ and Chung SC: Upregulation of heme oxygenase-1 and p21 confers resistance to apoptosis in human gastric cancer cells. Oncogene 23: 503-513, 2004. (Pubitemid 38175005)
17. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, Ito Y, Inamura T, Ikezaki K, Fukui M, Iwaki T and Kuwano M: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5: 1107-1113, 1999. (Pubitemid 29233226)
18. Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A and Maeda H: In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 63: 3567-3574, 2003. (Pubitemid 36793037)
19. Sacca P, Meiss R, Casas G, Mazza O, Calvo JC, Navone N and Vazquez E: Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. Br J Cancer 97: 1683-1689, 2007. (Pubitemid 350249355)
20. Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y and Maeda H: Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br J Cancer 88: 902-909, 2003. (Pubitemid 36520878)
21. Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ and Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693-698, 2001. (Pubitemid 32588025)
22. Jazwa A, Loboda A, Golda S, Cisowski J, Szelag M, Zagorska A, Sroczynska P, Drukala J, Jozkowicz A and Dulak J: Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratino-cytes. Free Radic Biol Med 40: 1250-1263, 2006.
23. Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S and Abraham NG: Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis 6: 15-24, 2003. (Pubitemid 37305335)
24. Marinissen MJ, Tanos T, Bolos M, de Sagarra MR, Coso OA and Cuadrado A: Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpes-virus-encoded G protein-coupled receptor. J Biol Chem 281: 11332-11346, 2006. (Pubitemid 43855558)
25. Cisowski J, Loboda A, Jozkowicz A, Chen S, Agarwal A and Dulak J: Role of heme oxygenase-1 in hydrogen peroxide-induced VEGF synthesis: effect of HO-1 knockout. Biochem Biophys Res Commun 326: 670-676, 2005. (Pubitemid 39642777)
26. Hirai K, Sasahira T, Ohmori H, Fujii K and Kuniyasu H: Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice. Int J Cancer 120: 500-505, 2007. (Pubitemid 44969019)
27. Gandini NA, Fermento ME, Salomón DG, Blasco J, Patel V, Gutkind JS, Molinolo AA, Facchinetti MM and Curino AC: Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp Mol Pathol 93: 237-245, 2012.
28. Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, Toyooka H and Yoshida H: Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Lett 138: 53-59, 1999. (Pubitemid 29189184)
29. Lin Q, Weis S, Yang G, Weng YH, Helston R, Rish K, Smith A, Bordner J, Polte T, Gaunitz F and Dennery PA: Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J Biol Chem 282: 20621-20633, 2007. (Pubitemid 47100046)
30. Walsh K, Sriprasad S, Hopster D, Codd J and Mulvin D: Distribution of vascular endothelial growth factor (VEGF) in prostate disease. Prostate Cancer Prostatic Dis 5: 119-122, 2002. (Pubitemid 34777894)
31. Sasco AJ, Secretan MB and Straif K: Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 2: S3-S9, 2004. (Pubitemid 39488165)
32. Aragon-Ching JB: Active surveillance for prostate cancer: has the time fnally come? J Clin Oncol 28: e265-e266, 2010.
33. Aragon-Ching JB, Madan RA and Dahut WL: Angiogenesis inhibition in prostate cancer: current uses and future promises. J Oncol 2010: 361836, 2010. World Health Organization. Tobacco 2011 [cited]. Available from: http://www.who.int/mediacentre/factsheets/fs339/en/index.html
34. Schacter BA and Kurz P: Alterations in hepatic and splenic microsomal electron transport system components, drug metabolism, heme oxygenase activity, and cytochrome P-450 turnover in Murphy-Sturm lymphosarcoma-bearing rats. Cancer Res 42: 3557-3564, 1982. (Pubitemid 12054460)
35. Deininger MH, Meyermann R, Trautmann K, Duffner F, Grote EH, Wickboldt J and Schluesener HJ: Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Res 882: 1-8, 2000.
36. Goodman AI, Choudhury M, da Silva JL, Schwartzman ML and Abraham NG: Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214: 54-61, 1997
37. Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M and Maeda H: Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 80: 1945-1954, 1999 (Pubitemid 29391278)
38. McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K and Moses AV: Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103: 3465-3473, 2004 (Pubitemid 38525679)
39. Berberat PO, Dambrauskas Z, Gulbinas A, Giese T, Giese N, Künzli B, Autschbach F, Meuer S, Büchler MW and Friess H: Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res 11: 3790-3798, 2005. (Pubitemid 40685598)
40. Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner O, Selzer E, Sperr WR, Valent P and Sillaber C: Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Res 64: 3148-3154, 2004. (Pubitemid 38581416)
41. Ferrara N, Mass RD, Campa C and Kim R: Targeting VEGF-A to treat cancer and age-related macular degeneration. Annu Rev Med 58: 491-504, 2007 (Pubitemid 46706529)
42. Shibuya M: Vascular permeability/vascular endothelial growth factor. In: Angiogenesis: An Integrative Approach from Science of Medicine. Folkman J and Figg WD (eds). Springer, New York, NY, pp89-98, 2008.
43. Li X, Claesson-Welsh L and Shibuya M: VEGF receptor signal transduction. Methods Enzymol 443: 261-284, 2008.
44. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841-844, 1993. (Pubitemid 23132159)